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ABSTRACT 
Characterization and genetic manipulation of ergot pathway 
inefficiency in fungi 
 
Prashanthi Mulinti 
Ergot alkaloids are mycotoxins that negatively affect humans and animals but also have useful 
pharmaceutical properties. Ergot alkaloids have been extensively studied in Claviceps purpurea, 
and also have been reported in other fungi, such as certain Penicillium spp., Aspergillus 
fumigatus, and several Neotyphodium spp. that are endophytes of grasses. There is a high 
degree of variation in the production of ergot alkaloids within an individual species and among 
producers from different taxa, which means different fungi accumulate different profiles of ergot 
alkaloids rather than a single pathway end product. These varied profiles result, in part, from 
inefficiency in the pathway which leads to increased accumulation of certain pathway 
intermediates in addition to the end product of the pathway. These intermediates have different 
biological activities and provide different benefits to the host than the pathway end products. I 
conducted a series of experiments to investigate the potential mechanisms by which fungi 
accumulate different profiles of intermediates and end products. In A. fumigatus, efficiency in 
completing the pathway varied developmentally. Wild type conidiating cultures containing all cell 
types involved in conidiation (hyphae, vesicle of conidiophore, phialides of conidiophore, and 
conidia) accumulated more of the pathway intermediate festuclavine and less of the pathway 
end product fumigaclavine C than did isolated mature conidia. Such differences also were 
indicated by studies with a medA mutant, which proliferates phialides. The medA mutant 
accumulated more pathway intermediates than did the wild type or a complemented medA 
mutant. A stuA mutant, lacking recognizable conidiophores, produced no detectable ergot 
alkaloids. Although this variation in alkaloid accumulation indicated a difference in distribution or 
activity of ergot pathway enzymes, fluorescence associated with the expression of five tested 
alkaloid pathway genes indicated a similar pattern of expression of each gene in the different 
cell types. Fluorescence was not observed in young hyphae but was detected at the apices of 
hyphae as they swelled to form the vesicle of the conidiophore. More fluorescence was 
observed in mature vesicles, phialides, and conidia. No qualitative differences were observed in 
cell type-specific expression of different pathway genes, indicating that observed differences in 
accumulation of intermediates versus end product must be due to quantitative differences in 
expression or differences in activity of pathway enzymes. In Neotyphodium lolii × Epichloë 
typhina isolate Lp1, an endophytic symbiont of perennial ryegrass, different ergot alkaloid 
profiles were observed in different tissues of the host plant. RNA interference (RNAi) and over-
expression of the easA gene genetically manipulated the flux of metabolites down the pathway. 
When compared to wild type, knock-down of easA gene resulted in higher accumulation of a 
pathway intermediate and a shunt product in comparison to pathway end product. In contrast, 
over-expression of easA resulted in higher accumulation of the pathway end product and no 
significant difference in the accumulation of intermediates and shunt products of the pathway. 
Collectively, my results indicated that the efficiency of the ergot pathway varies at cellular level 
in A. fumigatus and at the tissue level in Neotyphodium sp. Lp1. Also,in Neotyphodium sp. Lp1, 
efficiency in the flow of intermediates down the ergot alkaloid pathway can be manipulated by 
altering the expression of easA.
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Overview 
Ergot alkaloids were first discovered in the sclerotia of the ergot fungus, Claviceps 
purpurea. They are mycotoxins that exert toxic effects on humans and animals.  While 
ergot alkaloids are better known for their toxicity, they also have pharmaceutical 
properties (Pertz and Eich, 1999; Tudzynski et al., 2001; Panaccione and Schardl, 
2003). Ergot alkaloids have been extensively studied in C. purpurea, and are also 
reported in other species, such as certain Penicillium spp., Aspergillus fumigatus, and 
several epichloae (Epichloë and Neotyphodium spp.) that are endophytes of grasses 
(Panaccione and Schardl, 2003; Schardl et al., 2006). There is a very high degree of 
variation in the types of ergot alkaloids produced within an individual and among 
producers from different taxa, which means different fungi accumulate different profiles 
of ergot alkaloids rather than a single pathway end product. Some of the variation in 
ergot alkaloid profiles results from inefficiency in the pathway which leads to 
accumulation of the pathway intermediates (Panaccione, 2005). The pathway is 
particularly inefficient in grass endophytes, which leads to high levels of intermediate 
and by-product accumulation relative to the end product of the pathway. This pathway 
inefficiency may be beneficial to the fungus because different ergot alkaloids have 
different biological activities and thus, could play a major role in the survival of the 
fungus.  
 
Ergot alkaloids and their historical significance 
Ergot alkaloids are a complex family of indole-derived mycotoxins with diverse biological 
activities. They affect humans and livestock, and the extent of damage depends on 
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various factors such as strength of the toxins, time of exposure, and the individual’s 
health. These alkaloids typically affect the central nervous, immune, circulatory and 
reproductive systems (Grocer and Floss, 1998; Pertz and Eich, 1999; Tudzynski et al., 
2001; Panaccione and Schardl, 2003). Historically, humans suffered from ergotism, also 
known as the “Devils curse” or “St. Anthony’s fire,” upon consumption of grain 
contaminated with sclerotia of the ergot fungus, Claviceps purpurea. The ergot alkaloids 
retain their activity even after the contaminated grain has been made into bread 
(Peraica et al., 1999). There are two distinct types of ergotism, gangrenous and 
convulsive ergotism, based on the type of alkaloid involved. Gangrenous ergotism 
results in gangrene of the limbs, and is usually caused by ergopeptine alkaloids, 
because of their vasoconstrictive properties. Convulsive ergotism, which is more 
typically caused by intoxication with ergot clavines or simple amides of lysergic acid, is 
characterized by hallucinations, involuntary muscle contractions and gastrointestinal 
problems. However, there is significant overlap in the types of symptoms induced by 
different ergot alkaloid sources. Ergotism is now a rare occurrence because of various 
precautions such as grain cleaning before milling which removes most of the alkaloids, 
and crop rotation. The last documented outbreak of ergotism due to ergot clavines was 
seen in India in 1975 (Peraica et al., 1999) and that due to ergotamine was reported in 
Ethiopia in 1977 (Demeke et al., 1979). However, ergot poisoning is still a major 
concern in domestic animals such as cattle, chicken, sheep, horses and pigs that 
usually feed on contaminated grasses or grains (Bennett and Klich, 2003; Fribourg and 
Waller 2005). It has been reported that cattle grazing on endophyte infected tall fescue 
have lowered average daily weight gains, higher body temperatures, rougher coats, 
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lowered prolactin production, and reduced conception rates (Fribourg and Waller, 
2005). Ergot alkaloids have also been shown to affect rabbits, insects, and bacteria 
(Eich and Pertz, 1999; Clay and Schardl, 2002; Panaccione and Schardl, 2003; Popay 
and Bonos, 2005; Panaccione et al., 2006; Potter et al., 2008). 
 Ergot alkaloids have high biological activity and a broad spectrum of 
pharmacological effects, hence they are of considerable importance to medicine. In 
general, the pharmacological effects of all the ergot alkaloids appear to result from their 
actions as partial agonists or antagonists at different adrenaline, dopamine, and 
serotonin receptors, which further affect nervous, circulatory, reproductive, and immune 
systems (Goetz and Diederich, 1992; Pertz and Eich, 1999; Ganetsky and Brush, 
2005). Their roles as agonists or antagonists vary depending on which receptors they 
bind (Stadler and Groger,1984). Ergot alkaloids in controlled doses can have a 
therapeutic effect, and have been used in medicine as anti-migraine agents 
(ergotamine), in treatment of Parkinson’s disease (bromocriptine), in treating post-
partum hemorrhages and mastopathy, and to induce uterine contractions in childbirth 
(ergonovine) (Kimball et al., 1989; Goetz and Diederich, 1992; Wadworth and Chrisp, 
1992; van Dongen and de Groot, 1995; Barceloux, 2008). They also have a sedative 
effect on the central nervous system. However, because of their lack of specificity for 
individual monoamine receptors, they have a propensity for undesirable side effects 
(Kozlovsky, 1999; Panaccione and Schardl, 2003). 
Ergot alkaloids may also be synthesized in vitro. During the 1940’s, a Swiss 
chemist named Albert Hofmann created the semi-synthetic ergot alkaloid lysergic acid 
diethylamide (LSD), which became a well known recreational drug (Hofmann, 1980). He 
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discovered the hallucinogenic properties of the drug after accidentally ingesting it. LSD 
was used by psychiatrists and the Central Intelligence Agency (CIA) (Bennett and Klich, 
2003). Use of LSD has been known to cause a condition known as serotonin syndrome, 
which is a condition that shares similar clinical features with convulsive ergotism (Eadie, 
2003; Ganetsky and Brush, 2005). 
 
Ergot alkaloid producing fungi 
The distribution of fungi producing ergot alkaloids appears to be non-coherent 
paraphyletic. Several fungi representing the two distantly related orders within the 
phylum Ascomycota, Eurotiales and Hypocreales, produce ergot alkaloids (Panaccione, 
2005). Within the Hypocreales, ergot alkaloids have been most extensively studied in 
the clavicipitaceous genus Claviceps and several fungi in the genera Epichloe and 
Neotyphodium, which live as endophytic symbionts in grasses (Panaccione and 
Schardl, 2003; Schardl et al., 2006). Claviceps spp. parasitize flowers of rye and related 
cereal and forage plants and produce fungal overwintering bodies, the ergot sclerotia 
that replace the host’s seeds. Consumption of grain or seeds contaminated with the 
sclerotia can cause ergotism in humans and other mammals. Neotyphodium spp. and 
their teleomorphs, Epichloë spp., are endophytes of cool-season grasses, such as tall 
fescue and perennial ryegrass (Schardl et al., 2006). Endophytic association of the 
plants can be either mutualistic or antagonistic (Clay and Schardl, 2002). Mutualistic 
association can be seen in the case of Neotyphodium spp. which live in the host plant 
asymptomatically, actively growing in the intercellular spaces and colonizing the plants 
more extensively at the base of the pseudostem. During flowering, the endophyte 
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colonizes the floral meristem wherein hyphae extensively colonize the seeds beneath 
the seed coat. Thus the next generation seedlings become pre-inoculated with the 
endophyte. The asexual fungi are transmitted only vertically via the infected seeds 
(Craven et al., 2001; Clay and Schardl, 2002; Malinowski and Belesky, 2006). These 
fungi have significant effects on their host plants such as increased tolerance to various 
biotic and abiotic factors, including increased resistance to herbivores. Endophyte 
infection has also been associated with increases in tiller number, seed production, and 
root growth (Bush et al., 1997; Schardl and Phillips, 1997; Clay and Schardl, 2002; 
Panaccione, 2005; Malinowski and Belesky, 2006).  
In pathogenic associations, the endophyte grows asymptomatically inside the 
host plant until the plant reaches the boot stage, after which the fungus reproduces 
sexually by producing a fungal sexual structure, called a stroma that inhibits the 
development of the grass inflorescence (Clay and Schardl, 2002). The most pathogenic 
of these fungi are transmitted only horizontally. Some of the endophytic fungi such as E. 
festucae can be transmitted both vertically and horizontally; they affect only some 
inflorescences by forming stromata, whereas other inflorescences on the same plant 
produce infected seeds (Schardl and Leuchtmann, 2005; Olejniczak and Lembicz, 
2007). 
Endophytes have also been associated with livestock toxicosis, which is 
attributed, at least in part, to the ergot alkaloids that they produce (Hill et al., 1994; 
Filipov et al., 1998; Gadberry et al., 2003). In the U.S.A., cattle and horses that grazed 
on tall fescue inhabited by the endophyte N. coenophialum suffer from fescue toxicosis, 
symptoms of which include low fertility, poor weight gain, poor milk production, low 
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immunity, and dry gangrene of the limbs and tail (Lyons et al., 1986; Porter and 
Thompson, 1992; Schardl and Phillips, 1997; Gadberry et al., 2003). Livestock toxicosis 
can also be caused by several Claviceps species, endophytic fungi such as Epichloë 
(anamorph Neotyphodium) spp. that complete their life cycles in association with cool-
season grasses symbionts (Schardl, 1996; Schardl et al., 2009). 
Several species of fungi belonging to the order Eurotiales, such as Aspergillus 
fumigatus (Spilsbury and Wilkinson, 1961) and Penicillium commune (Kozlovsky, 1999), 
which are common imperfect fungi, also produce ergot alkaloids. A. fumigatus is an 
opportunistic pathogen capable of growing at temperatures up to 55 ºC and surviving at 
70 ºC. It colonizes domestic and public buildings causing aspergillosis, especially in 
immune-deficient individuals. The fungus grows in moist areas, such as basements and 
ventilation system ducts; it also is ubiquitous outdoors, with higher concentrations in 
areas surrounding compost and waste removal facilities. The fungus reproduces 
asexually by producing conidia, which become airborne and can be inhaled by humans 
and animals. In some cases inhaled conidia can infect and cause disease, act as an 
allergen, cause toxicoses, or cause inflammatory responses (Fischer and Dott, 2003).  
 
Classes of ergot alkaloids 
Ergot alkaloids are group of natural biologically active compounds that range from 
simple tricyclic to more complex tetracyclic alkaloids. Ergot alkaloids are considered 
secondary metabolites because under ideal laboratory conditions, they are not essential 
for survival of the fungus, yet they have an effect on other organisms that are exposed 
to the fungus producing these alkaloids. The type of alkaloid produced depends on the 
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pathway enzymes present in the producing fungus and the efficiency of the particular 
pathway (Panaccione, 2005; Schardl et al., 2006). Ergot alkaloids are tryptophan 
derivatives that contain a basic tetracyclic ergoline ring structure, which is methylated at 
position N-6 (Fig. 1). Based on the substitutions present at the C-8 position of the 
ergoline ring, they may be broadly divided into three groups: clavines, ergopeptines, 
and simple amides of lysergic acid (Fig 1) (Flieger et al., 1997; Keller, 1999). Some 
clavines, which are usually considered as the simpler ergot alkaloids, are precursors of 
lysergic acid; whereas both simple amides and ergopeptines, non-ribosomally 
synthesized peptides, derivatives formed from lysergic acid and three hydrophobic L-
aminoacids (Panaccione et al., 2006b; Schardl et al., 2006). 
Clavines have been isolated from many Claviceps spp. and other non-ergot 
fungi. Clavines can be further differentiated based on the presence of double bond 
between carbon 8 and 9 or 9 and 10, or by presence of open form of ring D of the 
tetracyclic ergoline ring which can be found in chanoclavine and members within the 
subclass 6,7-secoergolines (Flieger et al., 1997). In some fungi such as A. fumigatus 
and Claviceps fusiformis, clavines are the ultimate end products of the ergot alkaloid 
pathway; however, in other ergot alkaloid-producing fungi they are intermediates to 
more complex ergot alkaloids or as products of shunts off the pathway. Based on 
feeding experiments using endophyte infected grasses in rabbits it was discovered that 
apart from causing toxicoses, clavines also affect food preference by reducing the 
appeal of the infected grasses (Panaccione et al., 2006a). 
Simple amides of lysergic acid include lysergic acid amide (ergine) (Fig. 1), 
ergonovine, lysergic acid-2-hydroxyethylamide, and lysergyl alanine (Panaccione and 
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Schardl, 2003; Panaccione et al., 2003). They are produced by various fungi such as C. 
paspali (accumulates ergine and lysergic acid-2-hydroxyethylamide), C. purpurea 
(accumulates ergonovine and lysergyl-alanine), Neotyphodium sp. Lp1 and N. 
coenophialum (accumulate ergine and lysergyl-alanine). Based on knock-out analysis in 
Neotyphodium sp. Lp1, it has been determined that these alkaloids can accumulate as 
by-products of ergopeptine synthesis as seen in the case of ergine and lysergyl alanine 
(Panaccione and Schardl, 2003) or they can accumulate as ultimate end products of the 
ergot pathway as in ergonovine in C. purpurea (Ortel and Keller, 2009).   
Ergopeptines, also known as cyclol ergot alkaloids are the most complex ergot 
alkaloids. They were also the first to be isolated and studied. They are nonribosomally-
synthesized peptides that have three L-amino acids attached to D-lysergic acid via 
peptide bond, which is catalyzed by a lysergyl peptide synthetase complex (Riederer et 
al., 1996). The LPS complex is made up of two separate polypetides, LPS2 that 
activates D-lysergic acid by adenylation, and LPS1, which recognizes and activates the 
amino acids and forms the ergopeptines. Based on the amino acids that occupy 
positions I and II of the tripeptide chain attached to lysergic acid, there is variation in the 
composition of the ergopeptines (Fig. 2). Usually position III of the tripeptide chain is 
occupied by amino acid proline, with the only exception being ergobalansine, where 
position III is occupied by alanine (Keller, 1999). Based on the amino acid in position I of 
the peptide, ergopeptines can be divided into three subclasses: the ergotamine group, 
ergotoxine group, and ergoxine group. Based on the amino acid residing in position II 
there is lot of variation in individual ergot alkaloids within subclasses (Table 1). Possible 
amino acids occupying this position are phenylalanine, leucine, isoleucine, valine, and 
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alpha-amino butyric acid (Schardl et al., 2006). Ergovaline is a major alkaloid found 
within Neotyphodium spp., whereas ergosine and ergotamine are examples of abundant 
ergopeptines within Claviceps spp. (Lyons et al., 1986; Panaccione, 2005). 
Ergopeptams, are also known as noncyclol lactam ergot alkaloids, due to the 
lack of hydroxylation reaction at the amino acid adjacent to lysergic acid (position I); 
hence a cyclol bridge is unable to form with the amino acid in position III. They differ 
from ergopeptines in having a D- proline and a noncyclol lactam tripeptide chain (Flieger 
et al., 1997; Keller, 1999). Ergopeptams are further classified into the subclasses, 
ergotamams, ergoxams, ergotoxams, and ergoannams based on aminoacid in positions 
I and II (Table 2). 
 
Diversity in the production of ergot alkaloids among producing fungi 
Based on ergot alkaloid profiles and gene cluster analysis it has been elucidated that 
ergot alkaloid producing fungi belonging to Hypocreales and Eurotiales, two distant 
ascomycete orders, share early steps of the ergot alkaloid pathway; alternate pathways 
diverge after these common early steps resulting in the production of different sets of 
ergot alkaloids in different ergot alkaloid producing fungi. Aspergillus fumigatus, 
belonging to order Eurotiales, accumulates several simple clavine alkaloids with a 
saturated D ring like festuclavine, fumigaclavine A, and fumigaclavine B in the process 
of producing the ultimate pathway end product fumigaclavine C. It does not produce any 
complex lysergyl alkaloids (Coyle and Panaccione, 2005). Whereas several Claviceps, 
Epichloe and Neotyphodium species (family Clavicipitaceae) usually accumulate a more 
complex combination of clavines, ergopeptines, and simple amides of lysergic acid 
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(Panaccione et al., 2006b). Neotyphodium sp. Lp1, an endophyte of perennial ryegrass, 
accumulates relatively high concentrations of clavines and the ergopeptine ergovaline 
(Panaccione et al., 2003; Panaccione et al., 2006b), but this accumulation may vary in 
different host tissues (Table 3). Different species of Claviceps accumulate different 
alkaloids in their overwintering structures, sclerotia (“ergots”). Claviceps fusiformis 
accumulates clavines up through elymoclavine, and it completely lacks ergopeptines 
and simple amides (Lorenz et al., 2007). C. purpurea accumulates mostly simple 
amides of lysergic acid and ergopeptines (Tudzynski et al., 2001), whereas C. africana, 
an ergot fungus of sorghum has high levels of clavines and dihydroergot type of 
ergopeptines (Panaccione and Schardl, 2003). 
 
Ergot alkaloid pathway inefficiency 
In addition to the above indicated diversity in the ergot alkaloid profiles among different 
fungi, ergot alkaloid structure and function also differ within an individual ergot alkaloid 
producer. The ergot alkaloid pathway is relatively long (Fig.3) and product of the 
pathway is not one single toxin but a mixture of end product, one or more intermediates 
which accumulate to high concentrations, and alternate products that are produced by 
short shunt pathways off of the main pathway (Panaccione, 2005). These shunt 
pathways may influence pathway flux or accumulation of intermediates through the 
main pathway, while also accounting for the production of additional products which 
contribute to the diversity of ergot alkaloid profile (Panaccione, 2005). Some of the most 
important shunt pathways include the ones that lead to the production of 6,7–
secolysergine in some Neotyphodium spp. endophytes (Panaccione et al., 2003) and 
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setoclavine in some of the endophytic fungi belonging to Clavicipitaceae (Panaccione 
and Schardl, 2003; Schardl et al., 2006). So, the ergot alkaloid pathway is considered 
inefficient because there is limited direct flow of intermediates into one final end product; 
instead there may be very high levels of intermediates accumulating at certain points in 
the pathway, and also, in certain producers, these intermediates are diverted into 
alternate products. In the perennial ryegrass endophyte Neotyphodium lolii x Epichloë 
typhina isolate Lp1, the pathway is considered to be highly inefficient because of high 
accumulation of intermediate (chanoclavine) and spur products (6,7-secolysergine and 
setoclavine) relative to the pathway end product (ergovaline) (Panaccione et al., 2003; 
Panaccione et al., 2006b). This flow of intermediates may also vary in different tissues 
(Table 3). This pathway is also evident in A. fumigatus were there is difference in the 
ergot alkaloid profile of mature conidia compared to the whole conidiating cultures 
(Table 4). Based on studies with model animals and knockout endophytes, it has been 
demonstrated that the pathway inefficiency, which results in accumulation of 
intermediates and alternate products in addition to the end product, provides an 
advantage to the producing fungus and its plant host (Panaccione et al., 2006a; Potter 
et al., 2008). These studies have shown that intermediates and end products have 
different biological activities, intermediates act as feeding deterrents and the pathway 
end products have effective anti-insect activity (Panaccione et al., 2006a; Potter et al., 
2008). The pathway inefficiency that is accounted for in these fungi could be a result of 
variation in the expression of different ergot alkaloid pathway genes. Different cell types 
(in case of A. fumigatus) or hyphal compartments in different contexts (in case of 
endophytes) could possibly express different subsets of ergot alkaloid pathway genes or 
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all cell types could express all pathway genes but their expression is modulated in such 
a way that it leads to accumulation of different ergot alkaloids. These questions can be 
answered based on results from the GFP-based assays in A. fumigatus and real-time 
PCR analysis in Neotyphodium sp. Lp1. 
 
Objectives and potential impact of current study 
The focus of this study is to understand the biochemistry of ergot alkaloid pathway 
inefficiency in two different fungal species which differ markedly in development and life 
history. Aspergillus fumigatus, a saprophytic and opportunistic human pathogen 
provides us with the advantage of studying the pathway inefficiency in the different cell 
types of the fungus. The other fungal species Neotyphodium lolii x Epichloë typhina 
isolate Lp1, an obligate symbiont of perennial ryegrass enables us to study and 
manipulate the pathway inefficiency in different tissues of the host plant. 
The objectives of this study were to: 
1. Investigate potential spatial basis for ergot alkaloid pathway inefficiency in A. 
fumigatus by application of GFP-based assays. 
2. Experimentally quantify the tissue specific variation of ergot alkaloid accumulation 
due to pathway inefficiency in endophyte infected grasses. 
3. Manipulate the ergot pathway inefficiency by genetically modifying the ergot alkaloid 
gene expression in perennial ryegrass endophyte Neotyphodium sp. Lp1 through 
overexpression and RNAi approaches. 
Endophyte associated livestock toxicoses cause significant problems in 
agriculture that might be ameliorated by using genetically modified endophytes 
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produced by strategies developed in this research. Analysis of the pathway inefficiency 
will aid in identifying the possible basis by which ergot alkaloid profiles are altered in 
different fungi, this information can be further utilized in regulating the ergot pathway for 
more beneficial purposes. Characterization of the ergot alkaloid pathway inefficiency 
and the ability to control the spectrum of alkaloids produced may lead to advances in 
these fields by providing a potential means of eliminating the undesired effects. 
Knockdown and overexpression study analysis from this research can be extended to 
other endophytic fungi were gene knockout studies are difficult to perform. 
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FIGURE LEGENDS  
Figure 1: Representatives of the three classes of ergot alkaloids. Ergot alkaloids 
contain a basic ergoline ring structure indicated by the letters A-D within the alkaloid 
ergine. Based on substitutions on C-8 (blue) and location of the double bond (red), ergot 
alkaloids are divided into three groups: clavines which include festuclavine, simple 
amides of lysergic acid represented by ergine and ergotamine which represents 
ergopeptines. 
 
Figure 2: Ergopeptines with varying amino acid substitutions. Ergopeptines are 
nonribosomally-synthesized peptides that have three L-amino acids attached to D-
lysergic acid. They can be differentiated based on specific amino acids that occupy 
position R1 and R2. Usually, proline occupies the position R3. The table shows the 
amino acids involved in the synthesis of six common ergopeptines. 
 
Figure 3: Overview of hypothesized ergot alkaloid pathways of A. fumigatus 
(indicated in red) and clavicipitaceous fungi (indicated in blue). DMAPP = 
dimethylallylpyrophosphate; PPO = pyrophosphate; Trp = tryptophan; DMAT = 
dimethylallyltryptophan. A. fumigatus and the clavicipitaceous fungi share early steps of 
the ergot alkaloid pathway up until chanoclavine after which A. fumigatus produces 
alkaloids indicated in red and clavicipitaceous fungi produce alkaloids indicated in blue. 
The pathways involved in 6,7-secolysergine and setoclavine synthesis are the shunt 
pathways that branch off the main pathway. 
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Table 1. Representation of different subclasses of ergopeptine alkaloids  
	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
	   Ergotamines	   Ergoxines	   Ergotoxines	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Position	  I	  	  	  	  	  	  	  Position	  II	  
	  Alanine	   	  α-­‐Amino	  butyric	  acid	   	  Valine	  
Phenyalanine	   Ergotamine	   Ergostine	   Ergocristine	  
Leucine	   α-­‐Ergosine	   α-­‐Ergoptine	   α-­‐Ergocryptine	  
Isoleucine	   β-­‐Ergosine	   β-­‐Ergoptine	   β-­‐	  Ergocryptine	  Valine	   Ergovaline	   Ergonine	   Ergopcornine	  
α-­‐Amino	  butyric	  acid	   Ergobine	   Ergobutine	   Ergobutyrine	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Table 2. Representation of different subclasses of ergopeptam alkaloids 	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   Ergotamams	   Ergoxams	   Ergotoxams	   Ergoannams	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Position	  I	  	  	  	  	  	  	  Position	  II	  
	  Alanine	   	  α-­‐Amino	  butyric	  acid	   	  Valine	   	  Isoleucine	  Phenyalanine	   Ergotamam	   Ergostam	   Ergocristam	   	  
Leucine	   α-­‐Ergosam	   α-­‐Ergoptam	   α-­‐Ergocryptam	   α,β-­‐Ergoannam	  Isoleucine	   β-­‐Ergosam	   β-­‐Ergoptam	   β-­‐Ergocryptam	   β,β-­‐Ergoannam	  Valine	   Ergovalam	   Ergonam	   Ergocornam	   	  
α-­‐Amino	  butyric	  acid	   Ergobam	   Ergobutam	   Ergobutyram	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Table 3. Percent of measured ergot alkaloids (molar basis) distributed among different  
intermediates and products in perennial ryegrass tissues infected with endophyte Lp11 
 
Ergot alkaloid Leaf blades2 Pseudostems Seeds 
Chanoclavine 45 25 2 
6,7-secolysergine 25 19 8 
Setoclavine 4 7 0 
Lysergic acid 0 0 12 
Ergine 6 5 26 
Lysergyl-alanine 1 0 5 
Ergovaline 18 45 48 
 
1 Preliminary data collected by D.G.Panaccione from multiple perennial ryegrass plants, 
cv.Rosalin, infected with Neotyphodium sp.Lp1. However, samples were not necessarily 
from the same individuals grown under identical conditions. 
 
2 Values summed with columns vary from 100% due to rounding of multiple individual 
values. 
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Table 4. Percent of measured ergot alkaloids (molar basis) distributed among different 
intermediates and products in cell types of cultured Aspergillus fumigatus1 
 
Ergot alkaloid Abscised conidial only2 Conidiating cultures3 
Festuclavine 8 65 
Fumigaclavine B 1 1 
Fumigaclavine A 4 6 
Fumigaclavine C  87 28 
 
1 Unpublished data collected by C.M.Coyle and D.G.Panaccione 
 
2 Agar based cultures of A.fumigatus that are grown inverted will abscise ( or shed) 
mature conidia, which then accumulate on the lid of the culture plate, and can be 
harvested separately from the remainder of the culture. 
 
3 Composite of hyphae, condiophore vesicles, conidiophore phialides, and conidia. 
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FIGURE 1. 
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FIGURE 2. 
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FIGURE 3. 
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CHAPTER-2 
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Spatial expression patterns of ergot alkaloid genes 
during conidiophore development in Aspergillus 
fumigatus 
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ABSTRACT 
Production of ergot alkaloids in the opportunistic fungal pathogen Aspergillus fumigatus 
is restricted to conidiating cultures, which typically accumulate several pathway 
intermediates at concentrations comparable to that of the pathway end product. I 
investigated the contribution of different cell types that constitute the multicellular 
conidiophore of A. fumigatus to the production of intermediates versus end product. 
Conidiating cultures (containing hyphae, vesicle of conidiophore, phialides of 
conidiophore, and conidia) accumulated more of the pathway intermediate festuclavine 
and less of the pathway end product fumigaclavine C than did isolated mature conidia. 
These data indicated differences in distribution or activity of ergot pathway enzymes. 
Such differences also were indicated by studies with conidiophore mutants. A medA 
mutant, which proliferates phialides, accumulated more pathway intermediates than did 
the wild type or a complemented medA mutant. A stuA mutant, lacking recognizable 
conidiophores, produced no detectable ergot alkaloids. Distribution of several ergot 
alkaloid pathway enzymes among different conidiophore cell types was investigated by 
labeling enzymes with autofluorescent proteins. Fluorescence associated with 
expression of each tested gene indicated a similar pattern of spatial expression. 
Fluorescence was not observed in young hyphae but was detected at the apices of 
hyphae as they swelled to form the vesicle of the conidiophore. More fluorescence was 
observed in mature vesicles, phialides, and conidia. No qualitative differences were 
observed in cell type-specific expression of different pathway genes, indicating that 
observed differences in accumulation of intermediates versus end product must be due 
to quantitative differences in expression or differences in activity of pathway enzymes.
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INTRODUCTION 
Ergot alkaloids are a complex family of tri- or tetracyclic mycotoxins that are derived 
from prenylated tryptophan and have diverse structures and biological activities 
(Schardl et al., 2006; Lorenz et al., 2009; Panaccione, 2010). Because of their ability to 
act as partial agonists or antagonists at different adrenaline, dopamine, and serotonin 
receptors they affect nervous, circulatory, reproductive, and immune systems. 
Symptoms include reduced fertility, changes in blood pressure, lowered immune 
response, hallucinations, disturbances in sleep-wake cycles and gangrene of the limbs.  
Several fungi, representing two distantly related orders (Eurotiales and 
Hypocreales) within the phylum Ascomycota produce ergot alkaloids (Schardl et al., 
2006; Panaccione, 2010). The ergot alkaloids of A. fumigatus, a common saprophyte 
and opportunistic pathogen in the order Eurotiales, belong to the simpler class of 
clavine alkaloids and include chanoclavine, festuclavine, fumigaclavine B, fumigaclavine 
A, and fumigaclavine C (Fig. 1) (Cole et al., 1977; Panaccione and Coyle, 2005). The 
synthesis of these alkaloids is controlled by specific genes in the ergot alkaloid pathway. 
Those that will be analyzed in the current study include the following: dmaW which 
controls the first determinant step of the ergot alkaloid pathway (Coyle and Panaccione, 
2005; Unsöld and Li, 2005); easC and easE which are required for the formation of 
chanoclavine (Lorenz et al., 2010; Goetz et al., 2011); easA which acts after 
chanoclavine and contributes to the formation of festuclavine (Cheng et al., 2010; Coyle 
et al., 2010); and, the last step of the pathway, which results in the formation of the end 
product fumigaclavine C, is controlled by easL (Unsöld and Li, 2005). 
Aspergillus fumigatus accumulates high concentrations of ergot alkaloids in or on 
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conidia (Panaccione and Coyle, 2005). The ergot alkaloid pathway of A. fumigatus is 
relatively long and several pathway intermediates accumulate to levels approaching or 
exceeding that of the pathway end product, fumigaclavine C (Panaccione, 2005; 
Panaccione and Coyle, 2005). Thus the ergot pathway is considered inefficient because 
there is no rapid flow of intermediates into one final end product. A sporulating culture of 
A. fumigatus develops four morphologically distinguishable cell types: long tubular 
vegetative hyphae that grow in a polar fashion by apical extension; an aerial 
conidiophore stalk that develops from the hyphae and terminates with a bulbous vesicle; 
the phialide of conidiophore, which repeatedly produces conidia; and, the conidium 
(Timberlake, 1991). The restriction of ergot alkaloids to conidiating cultures has been 
established (Coyle et al., 2007), but the location of ergot alkaloid biosynthesis within 
those cultures is unknown. Moreover, the documented inefficiency in converting ergot 
alkaloid pathway intermediates may conceivably have a basis in differential distribution 
of pathway enzymes among conidiophore cell types. The objectives for this current 
study were to investigate potential differences in conidiophore cell-type specific 
production of ergot alkaloids by separating cell types (where possible), to study ergot 
alkaloid accumulation in conidiophore development mutants, and to determine the 
expression of ergot alkaloid pathway enzymes in specific cell types by tagging them 
with autofluorescent proteins. 
 
MATERIALS AND METHODS 
Fungi and culture conditions 
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Aspergillus fumigatus strain Af293 was used as the wild-type strain. Two different 
mutant strains derived from A. fumigatus Af293, ΔmedA (Gravelat et al., 2010) and 
ΔstuA (Sheppard et al., 2005), also were studied. All A. fumigatus strains were cultured 
on  potato dextrose agar [PDA; 20 g/L dehydrated potatoes (Idaho Spuds; Pillsbury, 
Minneapolis, MN), 20 g/L glucose, 15 g/L agar (Bacto agar; Difco, Detroit, MI)] at 37°C. 
For protoplast preparation, the fungi were cultured overnight in 15 mL of malt extract 
medium (50 g/L malt extract, 50 g/L lactose, 5 g/L asparagine, and 0.4 g/L K2HPO4) in a 
deep Petri dish (depth, 20 mm; diameter, 100 mm; Fisher Scientific, Pittsburgh, PA) on 
an orbital shaker (150 rpm) at 37°C. For fluorescent microscopy analysis, conidia from 
GFP-expressing A. fumigatus strains were inoculated on microscopic slides covered 
with glucose minimal medium (Shimizu and Keller, 2001) and incubated at 37°C. 
Analysis of ergot alkaloids 
Ergot alkaloids were extracted from ten sporulating culture plates each of the wild type 
and mutant A. fumigatus strains that were grown at 37°C for five days. Agar plugs 
containing 50.3 mm2 of colony surface area (cut with the broader end of a disposable tip 
for a P1000 Pipetman) of the A. fumigatus cultures were crushed and extracted in 0.5 
ml of 80% HPLC grade methanol as described by Coyle et al. (2007). Ergot alkaloids 
were quantified from 20 µL of the supernatant by high-pressure liquid chromatography 
(HPLC) over a C18 column [Prodigy 5 µm ODS3 (150 mm by 4.6 mm); Phenomenex, 
Torrance, CA] with acetonitrile-ammonium acetate gradients and detected by 
fluorescence (excitation and emission wavelengths of 272 nm and 372 nm, respectively) 
(Panaccione et al., 2003; Panaccione and Coyle, 2005). For spore versus whole culture 
ergot alkaloid analysis, the culture plates were first inverted and agitated to collect most 
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of the conidia on the lid. Conidia were then suspended in methanol to extract alkaloids. 
After removing most of the conidia an agar plug from the same culture plate was 
suspended in methanol to analyze ergot alkaloids of the whole culture. The spore only 
and whole culture suspensions were aliquoted for ergot alkaloid analysis and 
enumeration of conidia. Spore counts were performed on spore only extracts and whole 
culture extracts and alkaloids were expressed on a per spore basis. Peaks of alkaloids 
chanoclavine, festuclavine, fumigaclavine A, fumigaclavine B, and fumigaclavine C were 
detected based on methods employed in previous studies (Coyle and Panaccione, 
2005; Coyle et al., 2010). Quantification of ergot alkaloids were based on comparison of 
peak areas to those of the external standard agroclavine as described previously 
(Panaccione and Coyle, 2005). Data from spore-only versus entire culture extracts were 
analyzed by application of the Wilcoxon / Kruskal-Wallis (rank sums) test and those 
from medA mutant strain were analyzed by ANOVA and, when appropriate, the Tukey-
Kramer test. All analyses were performed with the JMP software package (SAS, Cary, 
NC).  
Generation of fluorescent protein tagged ergot alkaloid genes and transformation 
The intact ergot alkaloid genes dmaW, easE, easC, easA and easL which catalyze 
steps in the ergot pathway were amplified with their native promoters from wild-type 
strain Af293 with the primers listed in Table 1. All PCR reactions were performed on 
Bio-Rad C1000™ Thermal cycler and included 5X PCR buffer (Promega, Madison, WI), 
1.6 mM MgCl2, 200 µM dNTP, 1 µM each primer, 0.2 µg DNA and 1 U GoTaq Flexi 
DNA polymerase (Promega). Final volume for each reaction was 50 µL. The standard 
PCR profile was as follows: 3 min at 94° C, 35 cycles of 30s at 94° C, 30s at annealing 
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temperature, and 3 min at 72° C, followed by a final extension of 5 min at 72° C. The 
annealing temperature varied depending on the target (dmaW, 61.1; easE, 57.0; easC, 
57.7; easA, 52.0; easL, 52.0). For dmaW, easE, and easA genes, the amplified 
fragments lacking the stop codon, were cloned in frame with Cycle 3 GFP of the 
pcDNA3.1/CT-GFP-TOPO expression vector from the CT-GFP Fusion TOPO® TA 
Expression Kit (Invitrogen, Carlsbad, CA), according to manufacturer’s instructions. For 
easL, which catalyzes the final step of the ergot pathway, the gene lacking stop codon 
was amplified with gene specific primers and cloned as a BamHI–AgeI fragment into a 
red fluorescent pDSRed2 vector from Clontech Laboratories, Inc. (Palo Alto, CA). The 
recombinant vector, pXFP (X= dmaW, easE, easA and easL) allowed expression of 
ergot alkaloid genes with Cycle 3 GFP and RFP respectively fused at its C-terminus. 
For easC, a potential C-terminal peroxisomal signal (amino acid residues SRL) was 
observed, so an N-terminal GFP fusion plasmid [pXFP (X= easC)] was constructed in 
order to prevent any interference of the GFP with the signal. The orientation of the insert 
and sequence of all the plasmids were confirmed by sequencing. Protoplasts were 
prepared and transformed as described by Coyle et al. (2010). Cotransformation of the 
protoplasts was performed with the linearized fluorescent protein fusion construct, 
pXFP, and a hygromycin resistance plasmid, pMOcosX (Orbach, 1994), that had been 
linearized at a unique XhoI site (Coyle et al., 2007). Colonies growing on the 
transformation plates were screened for the presence of pXFP construct by PCR assay 
with primers that were specifically designed to target fluorescent protein coding 
sequence. In case of easC-GFP, a second transformant was made in which the GFP 
construct was targeted to the ergot gene cluster. This was done to test whether the 
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spatial pattern of expression was affected by the integration site of the GFP construct. 
Transformants were screened for homologous recombination of the plasmid peasCFP 
with the primer easCScrnF, which anneals to 5′ end of the easC gene and flanking the 
targeted site of integration and easCScrnR which anneals specifically to vector 
sequence (Table 1). Transformants yielding a fragment of 0.7 kb for homologous 
recombination at easC were purified to nuclear homogeneity along with transformants 
that had ectopic integration of easC by culturing them from individual, germinated 
conidia. Single spore colonies were again screened by PCR for the presence of pXFP 
fusion construct.  
Microscopic techniques 
Colonies of strains expressing GFP were visualized by a Nikon Eclipse TE2000-S 
inverted microscope (Nikon, Tokyo, Japan) equipped with a 100 W mercury vapor lamp. 
Green and red filter sets were used to detect the GFP and RFP proteins, respectively. 
Pictures were taken with a Q Imaging Retiga 2000R camera equipped with Qcapture 
2.90.1 software (Quantitative Imaging Corporation, Surrey, British Columbia, Canada) 
and processed with Adobe Photoshop CS5 (Adobe Systems Inc., San Jose, CA). 
 
RESULTS 
Ergot alkaloid content of whole sporulating cultures compared to mature, 
abscised conidia 
Cultures of wild-type A. fumigatus contained morphologically distinct cell types: 
vegetative hyphae, stalk with vesicle of conidiophore, phialides of conidiophore, and 
conidia. Samples from the entire culture (and thus containing all the four cell types) 
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contained an average of 3.3 fg of total ergot alkaloids per conidium, whereas samples 
made up exclusively of mature abscised conidia contained an average of 1.2 fg of total 
ergot alkaloids per conidium, indicating that cell types other than conidia contributed to 
the ergot alkaloid yield of the whole cultures. The difference in accumulation of total 
ergot alkaloids per spore between whole cultures (made up of different cell types) as 
compared to isolated, mature conidia was statistically significant (P=0.002). The 
proportion of festuclavine (the intermediate that accumulates to the highest 
concentrations) relative to total ergot alkaloids extracted was significantly greater in 
whole-culture extracts than in mature spore extracts (P=0.0002) (Fig. 2). The converse 
was true for the three alkaloids downstream from festuclavine, fumigaclavine B 
(P=0.0002), fumigaclavine A (P=0.0025), and fumigaclavine C (P=0.0002) (Fig. 2). 
Ergot alkaloid profiles of wild type, and ΔstuA and ΔmedA mutants and their 
complemented derivatives 
The ΔstuA mutant strain of A. fumigatus, lacking vesicles and phialides (Sheppard et al., 
2005), contained no detectable ergot alkaloids, and the corresponding complemented 
strain had a profile similar to that of the wild type (data not shown). In contrast, 
conidiating colonies of the ΔmedA mutant strain, which has multiple layers of phialides 
(Gravelat et al., 2010), accumulated higher amounts of total ergot alkaloids per 
conidium than did the wild-type (P=0.03). However, levels of the end product of the 
pathway (fumigaclavine C) were not significantly different in the ΔmedA mutant and 
wild-type (P=0.33) (Fig. 3A). The medA mutant, in comparison to the wild type, 
accumulated a significantly higher proportion of combined pathway intermediates 
(chanoclavine, festuclavine, fumigaclavine B, and fumigaclavine A) compared to levels 
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of pathway end product (fumigaclavine C) (P<0.0001) (Fig. 3B). 
Spatial localization of ergot alkaloid pathway genes during conidiophore 
development 
Ergot pathway gene products were observed at different time points in order to capture 
their localization patterns in all the asexual development stages of A. fumigatus. 
Fluorescence was not detected during the vegetative growth of the fungus and was first 
observed during conidiophore development. Similar spatial localization patterns were 
observed for all the genes tested in the study. In young conidiophores, the fluorescence 
was not randomly distributed but rather visualized as localized near the tip of the 
developing conidiophore (Fig. 4 A, E, I, M, Q) and to the zone that later became the 
phialide-bearing region of the conidiophore vesicle (Fig. 4 B, F, J, N, R). Extensive 
fluorescence was observed in the mature phialides that developed from the vesicle (Fig. 
4 C, G, K, O, S). Fluorescence was also observed in the conidia that developed from 
the mature phialides (Fig. 4 D, H, L, P, T). In the case of easL-RFP expressing A. 
fumigatus strain, greater fluorescence was observed in conidia relative to conidiophores 
(Compare Fig. 4 T and S) when compared to the relative fluorescence of conidia versus 
conidiophores of any of the other fluorescently labeled enzymes. The non-transformed 
wild-type strain did not fluoresce under the same observation conditions (data not 
shown). There was no difference in the expression patterns between the ectopic and 
cluster integrated easC-GFP expressing A. fumigatus strains (data not shown). 
 
DISCUSSION  
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Results from this study have provided new information on the developmental regulation 
of ergot alkaloid biosynthesis in A. fumigatus. Comparative alkaloid analysis of entire 
sporulating culture extracts and a spore only extracts demonstrated that ergot alkaloids 
are in fact produced in cell types that constitute a developing conidiophore in addition to 
the conidia of A. fumigatus. This was further confirmed by analysis of different cell-type 
mutants. The “medusa” mutant (ΔmedA), which has an abnormal phenotype with 
excess phialides and fewer conidia than wild-type (Gravelat et al., 2010), showed higher 
accumulation of pathway intermediates when compared to end products of the pathway. 
The “stunted” mutant (ΔstuA) with no vesicle or phialides and very few conidia 
(Sheppard et al., 2005) did not produce any detectable ergot alkaloids. Although this 
mutant produces very few conidia, the number of conidia extracted from the samples 
would have yielded ergot alkaloids at concentrations of at least 200-times the detection 
threshold if they contained alkaloids typical of wild-type conidia. These results raised the 
question of whether the pathway inefficiency that leads to differential accumulation of 
ergot alkaloids is due to cell-type specific expression of ergot alkaloid genes.  
 Autofluorescent protein expression studies of different ergot alkaloid pathway 
genes showed no detectable fluorescence in vegetative hyphae, supporting the 
hypothesis that these alkaloids are produced only during sporulation as opposed to 
during vegetative growth of the fungus (Coyle et al., 2007; Twumasi-Boateng et al., 
2009). Fluorescence was initially localized to the tips of hyphae that were differentiating 
into conidiophores; it was observed to be more evenly distributed in subsequent cell 
types. Spatial expression patterns were observed for all tested ergot alkaloid genes in 
specific cell types of the multicellular conidiophore, but no clear qualitative cell-type 
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specific differences in the expression of individual genes were detected. This suggests 
that quantitative differences in the expression of these genes in each cell type could 
account for the observed differential accumulation of intermediates versus end product 
of the ergot alkaloids pathway. Greater fluorescence of the easL-RFP construct was 
observed in conidia relative to conidiophores compared to the relative fluorescence of 
conidia versus conidiophores of any of the other fluorescently labeled enzymes. 
Whereas this difference is apparent from comparing the relevant panels in Fig. 4, 
definitive conclusions cannot be made because quantifying the fluorescence from 
different cell types is extremely difficult due to the close association of those cell types. 
Elevated expression of the reverse prenyl transferase encoded by easL in conidia as 
compared to conidiophores result in accumulation of end product fumigaclavine C to 
higher concentration in conidia. 
 Recent evidence from knock-out studies and transcriptome analysis have 
indicated that all ergot alkaloid genes of A. fumigatus are regulated by trans-acting 
transcription factors such as brlA and stuA (Coyle et al., 2007; Twumasi-Boateng et al., 
2009). Moreover, it has been shown that genes that are targeted by similar transcription 
factors are co-expressed (Marco et al., 2009). This may explain the overall similar 
spatial patterns of expression observed in case of all tested ergot alkaloid genes. 
Furthermore, in this study many of the GFP-fused ergot alkaloid gene constructs 
integrated ectopically in the genome; since these ergot alkaloid genes are regulated by 
trans-acting transcription factors, the effect of position in the genome should be minimal. 
This hypothesis is supported by the observations from the ectopic and cluster integrated 
easC-GFP expressing A. fumigatus strains. 
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 In conclusion, the ergot alkaloid pathway of A. fumigatus functions 
differently in different cell types associated with conidiation, resulting in higher 
concentrations of intermediates in extracts containing all cell types of conidiating 
cultures and higher concentration of end product in mature, abscised conidia. Several 
ergot alkaloid cluster genes are expressed in all cell types that constitute the mature 
conidiophore of A. fumigatus. Thus, pathway inefficiency which leads to higher 
accumulation of intermediates in certain cell types is not due to qualitative cell type-
specific expression of ergot alkaloid genes. However, the possibility that quantitative 
differences in expression of easL result in accumulation of the end product 
fumigaclavine C in conidia more than in conidiophores was supported by observation.  
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FIGURE LEGENDS  
Figure 1. Ergot alkaloid biosynthetic pathway of A. fumigatus. Multiple arrows indicate 
omitted intermediates. Steps catalyzed by genes included in the current study are 
indicated.   
 
Figure 2. Proportion of individual ergot alkaloids relative to the total ergot alkaloids 
extracted in a sporulating culture containing all cell-types (black bars) vs samples of 
abscised conidia (grey bars). A significant difference (P<0.05) was found when 
comparing each ergot alkaloid between sample types with the nonparametric Wilcoxon / 
Kruskal-Wallis rank sum test. Error bars represent standard error. The insert represents 
a magnified view (note scale on Y axis) of proportions of fumigaclavine A and B. 
 
Figure 3. Ergot alkaloid content of ΔmedA mutant versus wild-type A. fumigatus. (A) 
Total ergot alkaloids (black bars) and pathway end product fumigaclavine C (grey bars) 
among wild-type, ΔmedA mutant, and ΔmedA complemented strain. (B) Ratio of ergot 
alkaloid pathway intermediates (sum of chanoclavine, festuclavine, fumigaclavine A, 
and fumigaclavine B) to end product (fumigaclavine C) in wild type, ΔmedA mutant, and 
ΔmedA complemented strain. Standard error is shown by the error bars. Strains labeled 
with the same letter do not differ significantly according to the Tukey-Kramer honestly 
significant difference test (P<0.05).  
 
Figure 4. Spatial localization pattern of different ergot alkaloid genes of A. fumigatus 
during conidiophore development. Representative DIC and fluorescent images are 
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provided for strains expressing fluorescent protein tagged dmaW, easC, easE, easA, 
and easL ergot alkaloid pathway genes (A-T). Fluorescence localized to the tip of 
conidiophore stalk (fluorescence panel associated with A, E, I, M, and Q), the upper part 
of the vesicle that eventually becomes the phialide bearing region (fluorescence panel 
associated with B, F, J, N, and R), phialides of the conidiophore (fluorescence panel 
associated with C, G, K, O, and S), and conidia formed on mature conidiophores 
(fluorescence panel associated with D, H, L, P, and T). All images were captured under 
similar exposure time (1.98 s). Bar, 10µm. 
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TABLE 1. Primers used in this study. F, forward primer; R, reverse primer. 
Target 
gene 
Size 
(bp) 
5' UTR 
(bp) 
3' UTR 
(bp) 
Primer 
name 
Sequence 5'- 3' 
dmaW 2300 783 - dmaW-F 
 
dmaW-R 
GAGTGGTGTTGAGAGCTG
CCCAC 
GGTGGAGACCGGAATAAT
ATACCC 
easC 3358 1072 644 easC-F 
 
easC-R 
TGAACAGCTCGGGACTTAC
TTC 
CAGCAGATGGAGCAAGTG
ACTT 
easE 2619 650 - easE-F 
 
easE-R 
GAGAGTCATCTTGGATAAG
GGC 
GGCGGTATACCCGCTGGG
CAATGC 
easA 1915 787 - easA-F 
 
easA-R 
GTGCGGAGTGCCTACTCTA
TAG 
GGACGGGGAAATTATGCA
ATGC 
easL 2089 729 - easL-F 
 
easL-R 
GACGGATCCTTATTAGAGA
AGATGCTCTAAGTGG 
GCAACCGGTGGAAAGACG
GGTCGTGGCCCGCTG 
GFP 719   gfp-F 
 
gfp-R 
GCAGAATTCATGGCTAGCA
AAGGAGAAGAAC 
GCAGAATTCTTTGTAGAGC
TCATCCATGCC 
easC 746   easCScrnF 
 
easCScrnR 
GGGCTATGGTGAAGGATG
CTTCC 
CGGTCGCGGGATCGCGGG
CGAGG 
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FIGURE 1. 
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FIGURE 2. 
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FIGURE 3. 
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FIGURE 4. 
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Investigation and genetic modification of ergot 
alkaloid pathway efficiency of Neotyphodium lolii × 
Epichloë typhina isolate Lp1 (Neotyphodium sp. Lp1) 
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ABSTRACT 
The ergot alkaloid pathway of Neotyphodium lolii × Epichloë typhina isolate Lp1 
(Neotyphodium sp. Lp1), an endophytic symbiont of perennial ryegrass, is considered 
highly inefficient because of high accumulation of several pathway intermediates and 
shunt products in addition to the pathway end product. I investigated if pathway 
efficiency varied by tissue. My results demonstrated that different tissues of the host 
plant accumulated different profiles of ergot alkaloids as well as different total 
concentrations, indicating a potential tissue specific variation of expression of ergot 
pathway genes. Alteration of the expression of the ergot alkaloid pathway gene easA by 
RNA interference (RNAi) and over-expression techniques resulted in genetic 
manipulation of the flux of metabolites down the pathway. When compared to wild type, 
knock-down of easA resulted in higher accumulation of pathway intermediate 
chanoclavine and shunt product 6,7-secolysergine in comparison to pathway end 
product ergovaline. In contrast, over-expression of easA resulted in higher pathway 
ergovaline accumulation and no significant difference in the accumulation of 
intermediates and shunt products of the pathway. Collectively, my results indicate that 
ergot pathway genes are regulated differently in different tissues resulting in different 
profiles of ergot alkaloids. Also in Neotyphodium sp. Lp1, the concentration of easA 
mRNA has a significant role in controlling the efficiency in the flow of intermediates 
down the ergot alkaloid pathway.  
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INTRODUCTION 
Ergot alkaloids are mycotoxins that are derived from prenylated tryptophan and have 
varied biological activities (Schardl et al., 2006). They have been implicated in human 
toxicoses since medieval times. Toxic effects such as lowered immune responses, 
changes in blood pressure, hallucinations, gangrene of the limbs, reduced reproductive 
capability, and disturbances in sleep-wake cycle are caused by the ability of these 
alkaloids to act as partial agonists or antagonists at various serotonin, dopamine, and α-
adrenaline receptors (Goetz and Diederich, 1992; Pertz and Eich, 1999; Ganetsky and 
Brush, 2005). Several fungi, representing two distantly related orders, Eurotiales and 
Hypocreales, within the phylum Ascomycota produce ergot alkaloids (Schardl et al., 
2006; Panaccione, 2010). Within the Hypocreales, they have been most extensively 
studied in the clavicipitaceous genera Claviceps and several fungi in the genera 
Epichloë and Neotyphodium, which live as endophytic symbionts in grasses (Schardl et 
al., 2006; Panaccione, 2010). 
Neotyphodium spp. form symbiotic associations with cool-season grasses, such 
as tall fescue and perennial ryegrass, in which they grow in the intercellular spaces and 
colonize extensively at the base of the pseudostem. These endophytes are completely 
reliant on their host plant for existence and are transmitted only vertically via infected 
seeds (Clay and Schardl, 2002; Malinowski and Belesky, 2006). Neotyphodium spp. 
impart many significant traits to their host plants including tolerance to various biotic and 
abiotic stress factors and increased resistance to herbivores. They have also been 
associated with increases in tiller number, seed production, and root growth (Bush et 
al., 1997; Schardl and Phillips, 1997; Clay and Schardl, 2002; Panaccione, 2005; 
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Malinowski and Belesky, 2006). In spite of their positive impact on the grasses, 
Neotyphodium spp. endophytes often are considered undesirable because of their 
negative effects on livestock. They often cause livestock toxicosis which is at least in 
part attributed to the ergot alkaloids that they produce (Hill et al., 1994; Filipov et al., 
1998; Gadberry et al., 2003).  
 The ergot alkaloid pathway (Fig. 1) is relatively long and results in not just one 
final pathway end product but rather a mixture of end product, one or more 
intermediates, which accumulate to high concentrations, and alternate products that are 
produced by short shunt pathways off of the main pathway (Panaccione, 2005). These 
shunt pathways may influence pathway flux or accumulation of intermediates through 
the main pathway along with the production of additional products which results in the 
varied ergot alkaloid profile (Panaccione, 2005). So, the ergot alkaloid pathway is 
considered inefficient because there is reduced direct flow of intermediates into the final 
end product. Neotyphodium lolii × Epichloë typhina isolate Lp1 (Schardl et al., 1994), an 
endophyte of perennial ryegrass, produces a wide range of ergot alkaloids including 
clavines, ergopeptines, and simple amides of lysergic acid. In particular, Neotyphodium 
sp. Lp1, accumulates relatively high concentrations of the clavines chanoclavine and 
6,7-secolysergine and the ergopeptine ergovaline (Panaccione et al., 2003; Panaccione 
et al., 2006). Apart from these, it also accumulates ergine and lysergyl alanine as by-
products of ergopeptine synthesis. Based on studies with animal models and knockout 
endophytes, it has been demonstrated that the pathway inefficiency provides an 
advantage to the producing fungus and its plant host because both clavines and 
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lysergic acid derivatives provide benefits to the host plant (Panaccione et al., 2006; 
Potter et al., 2008).  
The objectives of this study were to investigate the potential reasons behind 
pathway inefficiency, determine if pathway efficiency varies between different tissues, 
and to manipulate the flow of metabolites through the ergot alkaloid pathway by altering 
the expression of easA employing RNA interference (RNAi) and overexpression 
strategies.  
 
MATERIALS AND METHODS 
Fungi and growth conditions.  
Neotyphodium sp. Lp1 was cultured on potato dextrose agar (PDA; 20 g/L dehydrated 
potatoes (Idaho Spuds; Pillsbury, Minneapolis, MN), 20 g/L glucose, 15 g/L agar [Bacto 
agar; Difco, Detroit, MI]) at 20°C. For protoplast preparation, the fungus was cultured for 
seven days in 50 mL of potato dextrose broth (PDB) in a 250 ml flask on an orbital 
shaker (200 rpm) at 20°C.  
Construction of easA RNAi and overexpression vectors. 
A standard PCR strategy was employed to generate RNAi and overexpression 
constructs. All PCR reactions included: 5X PCR buffer (Promega, Madison, Wl) with no 
magnesium, 1.6 mM MgCl2, 200 µM dNTP, 1 µM each primer, 0.2 µg DNA (from 
Neotyphodium sp. Lp1) and 1 U GoTaq Flexi DNA polymerase (Promega) in a 50 µL 
final volume. The standard PCR profile for all reactions was as follows: 3 min at 94°C, 
35 cycles of 30 s at 94°C, 30 s at 56°C and 3 min at 72°C, followed by a final extension 
of 5 min at 72°C. All primers used to generate these constructs are listed in Table 1.  
Generation of easA RNAi construct: 
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Using primers RNAi-1F and RNAi-2R, a DNA fragment was amplified containing 450 bp 
easA coding sequence, followed by 11 bp of an intron sequence from easG gene that 
was artificially engineered into the reverse primer because easA lacks any natural 
introns. In a second PCR with primers RNAi-3F and RNAi-4R, a DNA fragment was 
generated containing 36 bp of the remaining intron sequence of easG gene that was 
incorporated into the reverse primer followed by 450 bp of the easA coding sequence in 
reverse-complement orientation. After PCR, both fragments were pooled and digested 
with BsrGI (BsrGI recognition sites were built into primers RNAi-2 and RNAi-3) and 
ligated to yield a 947 bp fragment. The fragment was then digested with XhoI and NotI 
(recognition sites for which were built into the 5'-ends of primers RNAi-1 and RNAi-4, 
respectively), ligated into XhoI and NotI digested pCB1004, and electroporated into 
Escherichia coli cells. The resulting transformants were selected on chloramphenicol. 
The plasmid vector, pEASAi (Fig. 2A) was isolated, and integrity of the easA-RNAi 
construct was checked by sequencing into the insert from flanking vector regions. 
Sequencing of the coding regions of easA was greatly inhibited by secondary structure 
formation, so digestion with different restriction enzymes and analysis of the restricted 
fragments was performed to confirm that the desired construct had been obtained. 
Transcription of the easA-RNAi fragment was driven by a strong toxA promoter which 
was amplified from Pyrenophora tritici-repentis DNA with primers toxA-F and toxA-R 
and cloned as a KpnI-XhoI fragment into pCB1004, prior to cloning the easA-RNAi 
segment into the plasmid. The trpC terminator was amplified from Aspergillus nidulans 
trpC gene using primers trpC-F and trpC-R and inserted it at a unique SacI site in the 
plasmid. 
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Generation of easA overexpression construct: 
In order to overexpress the easA gene, easA coding sequence was fused to the 
promoter of gigA from Neotyphodium sp. Lp1 (Johnson et al., 2003), which is the most 
highly expressed endophyte gene during symbiosis. Using primers easAO-1 and 
easAO-2, the easA coding sequence was amplified as a 1551 bp DNA fragment 
containing NotI and BsrGI sites at the 5’ and 3’ end respectively. The promoter of Nc25 
was amplified as a 576-bp XhoI-BsrGI fragment with primers Nc25-F and Nc25-R. The 
PCR products were then purified, pooled, digested with BsrGI, and ligated. The 
resulting 2127 bp fragment was then digested with XhoI and NotI and cloned into XhoI 
and NotI digested pCB1004 vector and electroporated into E. coli cells. The plasmid 
vector, pEASAo (Fig. 2B) was isolated from transformants and integrity of the construct 
was checked by sequencing.  
Fungal transformation and plant infection. 
Protoplasts were prepared and transformed based on methods described by 
Panaccione et al. (2001). Transformants were selected for on a medium containing 200 
µg mL–1 hygromycin B (Calbiochem, San Diego, CA). After 5 weeks, viable hygromycin-
resistant fungal colonies were transferred onto PDA to induce sporulation. The 
transformants were then screened for integration of the desired plasmid construct by 
PCR by primers hyg-F and hyg-R, which target the hygromycin resistance gene of the 
plasmid. Positive transformants were purified to nuclear homogeneity by culturing them 
from single spores. Perennial ryegrass cv. Rosalin were inoculated with single-spored 
genetically modified endophytes according to methods described by Panaccione et al. 
(2001). 
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Analysis of ergot alkaloids. 
Ergot alkaloids were extracted from 50 mg of dried powdered plant material as 
described previously by Panaccione et al. (2006). Ergot alkaloids were quantified from 
20 µL of the supernatant by high-pressure liquid chromatography (HPLC) over a C18 
column (Prodigy 5-µm ODS3 [150 mm by 4.6 mm]; Phenomenex, Torrance, CA) with 
acetonitrile-ammonium acetate gradients. Chanoclavine was detected by a fluorescent 
detector set at excitation and emission wavelengths of 272 nm and 372 nm, 
respectively. All other ergot alkaloids were detected by excitation at 310 nm and 
emission at 410 nm (Panaccione et al., 2006). Quantification of ergot alkaloids was 
based on comparison of peak areas to those of internal standard ergotamine-tartrate 
(Sigma, St, Louis, MO) that was added to the plant material along with the extraction 
buffer. Data was analyzed by ANOVA using the general linear models procedure of 
SAS (Cary, NC). 
 
RESULTS 
Tissue specific accumulation of ergot alkaloids.  
Ergot alkaloids were detected and quantified in different perennial ryegrass tissues 
colonized with wild-type Neotyphodium sp. Lp1. Concentrations of total alkaloids that 
include pathway intermediate chanoclavine, shunt products 6,7-secolysergine and 
setoclavine, and end products ergine and ergovaline differed significantly in 
pseudostem, center leaf blade, outer leaf blade, flag leaf, inflorescence, and dough 
stage seeds (P = 0.0001) (Fig. 3). Dough stage seeds accumulated the highest 
conentrations of total alkaloids followed by pseudostems. Total alkaloids were of similar 
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concentrations in the outer leaf blade, center leaf blade and inflorescence but differed 
significantly from dough stage, pseudostem, and flag leaf. Flag leaf tissue had very low 
total alkaloid concentrations with only detectable 6,7-secolysergine and ergine alkaloids. 
Concentrations of individual alkaloids varied significantly within and among tissues 
representing different developmental stages of the plant (P < 0.05) (Fig. 4). Within 
individual tissues, dough stage seeds and pseudostems accumulate high amounts of 
pathway end product ergovaline when compared to all other alkaloids. Conversely, 
inflorescence tissue accumulates higher chanoclavine levels and lower amounts of 
other alkaloids. When concentrations of different alkaloids were compared among 
tissues, the pathway intermediate chanoclavine accumulated in significantly higher 
concentrations in pseudostems, inflorescence, and dough stage (P < 0.05) than in other 
tissues. Shunt product 6,7-secolysergine was detected in higher concentrations in 
dough stage seeds (P < 0.05), which also accumulated very high concentrations of 
pathway end products. Setoclavine was rarely detected in any of the host tissues.  
Transcript accumulation data were also looked at in terms of expression of 
individual genes in all the different tissues used in the study. This work was performed 
by Dr. Simona Florea in the laboratory of Dr. Christopher Schardl at the University of 
Kentucky and is described in Appendix 1. 
Ergot alkaloid analysis of the plants colonized by genetically modified endophyte 
strains. 
Alteration of mRNA levels of easA employing RNAi and overexpression strategies 
changed the flow of metabolites through the ergot alkaloid pathway of Neotyphodium 
sp. Lp1. When compared to the wild-type, plants colonized by two of the three different 
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strains of easA RNAi fungi and easA overexpressing Neotyphodium sp. Lp1 differed 
significantly in accumulation of ergot alkaloids (Fig. 5-8). Each strain represented an 
independent, random integration event. 
 
Alteration of ergot alkaloid profiles in pseudostem and outer leaf blades of plants 
infected by easA RNAi strains: 
Plants colonized by Neotyphodium sp. Lp1 strain in which easA has been knocked 
down by RNAi showed significant differences in the accumulation of an ergot alkaloid 
pathway intermediate, a by-product, and an end product. Pseudostems colonized by 
easA-RNAi-1 fungus had significantly higher accumulation of chanoclavine (P = 
0.0050), an early pathway intermediate, and 6,7-secolysergine, a pathway shunt 
product (P = 0.0075), and lower accumulation of ergovaline (P = 0.013), the end product 
of the pathway, than did pseudostems colonized with the wild type (Fig. 5A). Outer leaf 
blades from the same plants also accumulated significantly high concentrations of 6,7-
secolysergine (P = 0.0148) and less ergovaline (P = 0.0008) (Fig. 6A), when compared 
to the wild type. No detectable chanoclavine was found in the outer leaf blades. Similar 
results were measured in pseudostems and leaf blades colonized by strain easA-RNAi-
2 strain (Fig. 5B and 6B). In contrast, accumulation of ergot alkaloids in plants infected 
with strain easA-RNAi-3 did not differ significantly from that of wild type-infected plants 
(Fig. 5C and 6C). 
In collaboration with Drs. Florea and Schardl (University of Kentucky), transcript 
accumulation of easA was also looked at in the same samples of pseudostem that were 
used for alkaloid analysis (Appendix 1). 
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Alteration of ergot alkaloid profiles in pseudostem and outer leaf blades of plants 
infected by easA overexpression strains: 
Pseudostems colonized by easA-overexpression-1 strain had significantly more 
ergovaline, the pathway end product, (P = 0.014) and no significant difference in 
accumulation of intermediate chanoclavine and by-product 6,7-secolysergine (Fig. 7A), 
when compared to the wild type. Outer leaf blades from the same plants also 
accumulated significantly more ergovaline than plants infected with the wild type (P = 
0.018) (Fig. 8A). No difference in the levels of 6,7-secolysergine were detected in leaf 
blades when compared to the wild type (Fig. 8A). Chanoclavine was not detected in the 
outer leaf blades. Similar alkaloid concentrations and distribution was detected in 
pseudostems and leaf blades colonized by the easA-overexpression-2 strain (Fig. 7B 
and 8B). In contrast, easA-overexpression-3 strain did not show any significant 
difference in the accumulation of ergot alkaloids when compared to wild type (Fig. 7C 
and 8C). 
 In collaboration with Drs. Florea and Schardl (University of Kentucky), transcript 
accumulation of easA was also looked at in the same samples of pseudostem that were 
used for alkaloid analysis (Appendix 1). 
 
DISCUSSION 
Results from this study have provided new insights into how different ergot alkaloid 
profiles can result from differing efficiency in turning over intermediates in the ergot 
alkaloid pathway of Neotyphodium sp. Lp1 that is symbiotic with perennial ryegrass. 
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Results from analysis of different tissues of perennial ryegrass infected with the wild 
type showed that the ergot alkaloid pathway efficiency varies at tissue level. mRNA from 
various ergot alkaloid pathway genes was present in all tissue type (Appendix 1) but 
variation in levels of individual genes may account in part to the varied levels of 
alkaloids detected in these tissues. Through RNAi and over-expression transformant 
analysis, I have established that alteration of easA mRNA can change the efficiency of 
the ergot alkaloid pathway in Neotyphodium sp. Lp1. When compared to wild type, 
transformants with RNAi-mediated knock down of easA had higher accumulation of 
pathway intermediate chanoclavine and shunt product 6,7-secolysergine and lower 
accumulation of pathway end product ergovaline. Furthermore, over-expression of easA 
resulted in a very high accumulation of pathway end product ergovaline compared to 
the wild type, but there was no significant difference in the accumulation of intermediate 
chanoclavine and shunt product 6,7-secolysergine alkaloid.  
Results from analyses of ergot alkaloids in various tissues of perennial ryegrass 
showed that ergot alkaloid profiles differed by tissue, with some tissues, like dough 
stage of seeds, being more efficient in turning over intermediates and other stages, like 
inflorescences, being highly inefficient. Analyses of mRNA from several ergot alkaloid 
pathway genes indicate that ergot alkaloid pathway efficiency is influenced by the 
accumulation of mRNA for different ergot alkaloid pathway enzymes (Appendix 1). All 
the ergot pathway genes tested in the study were ubiquitously expressed in all the 
tissues, but there was differential expression of these genes in different tissues which 
may contribute to the difference in ergot alkaloid accumulation (Appendix 1). This is 
exemplified by the high abundance of lpsA mRNA in pseudostems and center leaf blade 
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and cloA in dough stage seeds which may contribute to the higher accumulation of 
pathway end product in these tissues (Appendix 1).  
In addition to variation in profiles, different tissues varied in accumulation of total 
ergot alkaloids. Pseudostems and dough stage seeds had higher accumulations of 
alkaloids, whereas flag leaf had very low levels of alkaloids which can be due to the low 
fungal biomass in flag leaf and higher fungal biomass in pseudostem and dough stage 
seeds (S. Florea and C.L. Schardl, pers.com). In addition to mRNA abundance, relative 
fungal colonization of different tissues, substrate availability in different tissues, and 
translocation of alkaloids from their site of synthesis also could affect the levels of 
alkaloids in different tissues. 
Neotyphodium sp. Lp1 is a systemic and seed-transmitted obligate symbiont of 
perennial ryegrass that is completely reliant on the host plant for its existence. Since the 
fungus is dispersed only via infected seeds (Schardl, 1996), it has to defend the host 
resources, thereby enhancing its frequency of transmission into the next generation. 
Therefore, an inefficient pathway that results in the varied profiles of alkaloids in 
different tissues would be selected for if intermediates and end products provided 
different benefits to the host plant. Recent evidence from studies with endophytes in 
which the ergot alkaloid pathway was truncated at different steps support the hypothesis 
that inefficiency in the ergot alkaloid pathway is beneficial (Panaccione, 2005; 
Panaccione et al., 2006; Potter et al., 2008). Moreover, since different stresses are 
likely to be encountered by different tissues, variation of pathway efficiency by tissue 
could be advantageous to the symbiotum. The plant’s basal meristem and seeds are 
most vital for the fungus to defend, which may account for the high amounts of total 
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detectable alkaloids in seeds and pseudostems, which protect the basal meristematic 
regions. The presence of alkaloids in leaves is a possible way of the endophyte to 
protect its host’s resources from grazing animals.  
Recent evidence has shown that knock out of easA in A. fumigatus, results in the 
accumulation of high concentrations of chanoclavine and lesser amounts of 
chanoclavine aldehyde (Coyle et al., 2010). So the product of easA is required for the 
formation of more complex tetracyclic ergot alkaloids, such as agroclavine, from the 
simple tricyclic alkaloids such as chanoclavine in Neotyphodium sp. Lp1 (Cheng et al., 
2010; Coyle et al., 2010). Analyses of different tissues of perennial ryegrass inhabited 
by Neotyphodium sp. Lp1 support previous findings that only trace quantities of 
intermediates such as agroclavine, elymoclavine, lysergic acid are detected between 
intermediate chanoclavine and pathway end product ergovaline (Panaccione et al., 
2003; Panaccione, 2005). This suggests that once agroclavine, the first tetracylic 
intermediate, is formed, the pathway flows very efficiently and results in the production 
of ergovaline. Although alkaloid and mRNA results from RNAi-mediated knock down of 
easA suggest that easA strongly affects the efficiency in the flow of intermediates down 
the ergot alkaloid pathway after the formation of chanoclavine, alkaloid and mRNA data 
from easA overexpression analyses indicated no change in the levels of chanoclavine. 
When easA is over expressed all the intermediate chanoclavine should be converted 
into further downstream alkaloids. The fact that we do not see any change in levels of 
chanoclavine of overexpression strains in comparison to the wild-type indicates that 
when chanoclavine levels fall below the threshold value it probably results in up 
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regulation of the genes upstream to easA. This upregulation could have further led to 
increased chanoclavine accumulation. 
Endophytes, by means of their ergot alkaloid production, impart toxic properties 
to their host plants, making them less desirable as forage crops. Toxicity can be 
possibly ameliorated by using endophytes with altered ergot alkaloid profiles. Symbiota 
with genetically altered ergot alkaloid profiles generated by this study may be used to 
differentiate the role of individual ergot alkaloids in animal toxicity and in other 
endophyte associated traits. Since the endophyte is transmissible only via seeds the 
generation and incorporation of agronomically desired traits conferred by genetically 
modified endophytes may provide a viable strategy in controlling animal toxicity. 
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FIGURE LEGENDS  
Figure 1: Condensed version of the ergot alkaloid biosynthetic pathway of 
Neotyphodium sp. Lp1. Multiple arrows indicate omitted intermediates.  
 
Figure 2: Schematic representation of easA RNAi and overexpression constructs. (A) 
Map of the RNAi plasmid construct containing the easA sequence under the control of 
the toxA promoter from Pyrenophora tritici-repentis and the trpC terminator from A. 
nidulans. The elements of the plasmid are represented by open and shaded boxes 
which are, respectively, the coding regions of easA, artificially engineered intron 
(sequence indicated by lowercase letters) between the complementary easA coding 
sequences (represented by uppercase letters). The underlined sequence indicates the 
BsrGI recognition sequence introduced for cloning. (B) Map of the easA overexpression 
plasmid construct containing the easA sequence driven by the gigA promoter derived 
from Neotyphodium sp. Lp1. 
 
Figure 3: Total ergot alkaloid levels in pseudostem, center leaf, outer leaf, flag leaf, 
inflorescence and dough stage seeds of the perennial ryegrass infected with wild-type 
Neotyphodium sp. Lp1 (n=3). 
 
Figure 4: Accumulation of indicated ergot alkaloids in pseudostem, center leaf, outer 
leaf, flag leaf, inflorescence and dough stage seeds of the perennial ryegrass plant 
infected with wild-type Neotyphodium sp. Lp1 (n=3). 
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Figure 5: Levels of indicated ergot alkaloids in pseudostem tissue of perennial ryegrass 
infected with (A) easA RNAi-1, (B) easA RNAi-2 and (C) easA RNAi-3 transformant 
Neotyphodium sp. Lp1 strains. Asterisks represent significant differences (P< 0.05) 
between transformant and wild type (n=3). 
 
Figure 6: Levels of indicated ergot alkaloids in leaf tissue  of perennial ryegrass 
infected with (A) easA RNAi-1, (B) easA RNAi-2 and (C) easA RNAi-3 transformant 
Neotyphodium sp. Lp1 strains. Asterisks represent significant differences (P< 0.05) 
between transformant and wild type. 
 
Figure 7: Levels of indicated ergot alkaloids in pseudostem tissue  of perennial 
ryegrass infected with (A) easA overexpression -1, (B) easA overexpression -2 and (C) 
easA overexpression -3 transformant Neotyphodium sp. Lp1 strains. Asterisks 
represent significant differences (P< 0.05) between transformant and wild type (n=3). 
 
Figure 8: Levels of indicated ergot alkaloids in leaf tissue of perennial ryegrass infected 
with (A) easA overexpression -1, (B) easA overexpression-2 and (C) easA 
overexpression-3 transformant Neotyphodium sp. Lp1 strains. Asterisks represent 
significant differences (P< 0.05) between transformant and wild type (n=3). 
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Table 1: Primers used in this study. F, forward primer; R, reverse primer. 
Primer 
name 
Sequence 5'- 3' 
RNAi-1F 
RNAi-2R 
CACCTCGAGGCTGTGTTTGCGCATCATTATGTC 
CACTGTACAAATAGTCATACCCGATGTATGAGTTGATCTCATC
G 
RNAi-3F 
 
RNAi-4R 
CACTGTACAGTTAGAACAAAGAATGAAATTAACGTATAACGAT
AGCCGATGTATGAGTTGATCTCATCG 
GATCTATGCGGCCGCGGCTGTGTTTGCGCATCATTATGTC 
toxA-F 
toxA-R 
TAGTGGGGTACCGGAATCCATGGAGGAGT 
GATAGAACTCGAGCCTATATTCATTCATT 
trpC-F 
trpC-R 
TGACGTGAGCTCTAGTGATTTAATAGCTCCAT 
GATAGAGAGCTCCATTCACTAGGCAACCATGGTTAC 
easAO-1-F 
easAO-1-R 
CACTGTACAGCTGTGTTTGCGCATCATTATGTC 
GACGCGGCCGCCCTTGGGTTATCCTACCGACTACA 
Nc25-F 
Nc25-R 
GTACTCGAGCTACTGCGTATAGAGTAGTGAGTA 
CACTGTACAGGTGAACGTTTTTGACTGTTG 
hyg-F 
hyg-R 
CCGTGGAGGTAATAATTGA 
CGAAGAACGTTTTCCAATGA 
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FIGURE 1. 
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FIGURE 2. 
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FIGURE 3. 
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FIGURE 4. 
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FIGURE 5. 
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FIGURE 6. 
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FIGURE 7. 
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FIGURE 8. 
 
 
 
 
 0
0.5
1
1.5
2
6,7-secolysergine Ergovaline
WT
easA-Overexpression
0
0.5
1
1.5
2
6,7-secolysergine Ergovaline
E
rg
o
t 
al
ka
lo
id
 
(n
m
o
l/g
 o
f 
le
af
 t
is
su
e)
0
0.5
1
1.5
2
6,7-secolysergine Ergovaline
E
rg
o
t 
al
ka
lo
id
 
(n
m
o
l/g
 o
f 
le
af
 t
is
su
e)
E
rg
o
t 
al
ka
lo
id
 
(n
m
o
l/g
 o
f 
le
af
 t
is
su
e)
A B C
*
*
	   84	  
 
 
 
 
APPENDIX-1 
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Real-time PCR analysis of grass symbiota 
containing wild-type and transformed 
Neotyphodium lolii × Epichloë typhina isolate 
Lp1 (Neotyphodium sp. Lp1). 
 
Original data from research by Dr. Simona Florea, University of Kentucky 
Summarized by Prashanthi Mulinti 
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INTRODUCTION 
Dr. Florea performed real-time PCR analysis on the same pseudostem tissues that 
were analyzed for ergot alkaloids in Chapter 2, to check the accumulation of mRNA 
from certain ergot alkaloid cluster genes. I am summarizing Dr. Florea’s findings here, 
because comparison of alkaloid and mRNA data will provide important information 
about factors affecting flow of intermediates through the ergot alkaloid pathway. 
 
MATERIALS AND METHODS 
Tissue collection and RNA isolation 
Pseudostems were collected from plants inoculated with Neotyphodium sp. Lp1 and 
rapidly frozen in liquid nitrogen. Total RNA was isolated from 100 mg of each sample by 
application of the RNeasy Plant Mini kit (Qiagen, Valencia, CA, USA) according to 
manufacturer’s instructions. The RNA integrity was determined by agarose gel 
electrophoresis. 
DNase treatment and Reverse transcription 
The total RNA was treated for removal of contaminating DNA with DNA-free kit 
(Ambion, Austin, TX) and quantified by Qubit fluorometer (Invitrogen, USA) following the 
recommendations of Quant-iT RNA Assay Kit. The cDNA was synthesized from 1 µg 
RNA by application of the High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems) according to manufacturer’s instructions. 
 
Real-Time quantitative PCR (RT-qPCR) 
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The RT-qPCR assays were performed in 7900 HT Fast Real-Time PCR System 
(Applied Biosystems) employing SYBR green detection. The RT-qPCRs were 
conducted in 96-microwell plates, where each sample-gene combination was loaded in 
triplicate. The reactions contained 5 µL of cDNA, 10 µL SYBR mix and 0.4 µM of each 
primer in a final reaction volume of 20 µL. The primers for the target genes (dmaW, 
easA, cloA, lpsA, easC, and easD) and the reference genes (tefA and EF1-α) were 
generated by IDT (Coraville, IA, USA) and are listed in Table 1. The relative 
metabolically active fungal biomass in different tissues was estimated by measuring the 
mRNA level of fungal gene tefA (encoding translation elongation factor 1- α) with the 
plant translation elongation factor 1-α (EF1-α) mRNA as reference. Expression of all 
tested genes was calculated with the relative comparative Ct method (ΔΔCt = 
normalized Ct as ΔCt – calibrator, where ΔCt = Ct of target gene – Ct of tefA, and 
calibrator = median of ΔCt), using tefA as the reference gene for normalization. For 
each gene, the relative level of gene expression was then converted into fold-difference 
relative to the calibrator as 2−ΔΔCt (Livak and Schmittgen 2001).  
 
RESULTS AND DISCUSSION 
Real-time data indicated that although there is ubiquitous expression of all pathway 
genes tested in all the tissues, significant differences in mRNA abundance of different 
pathway genes was detected among different tissues (P<0.05) (Fig. 1). The high mRNA 
abundance of lpsA, which is required for the formation of pathway end product 
ergovaline (Panaccione et al., 2001), in pseudostem and center leaf is consistent with 
the higher accumulation of ergovaline in these tissues. The high mRNA levels of cloA, 
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which catalyzes the formation of lysergic acid from elymoclavine (Haarmann et al., 
2006), in dough stage seeds is consistent with higher accumulation of end products of 
the pathway. Within an individual tissue there was no significant difference in the 
abundance of mRNA of different pathway genes indicating that factors other than 
mRNA abundance contribute to the accumulation of alkaloids in different tissues.  
RT-PCR analysis also was performed on pseudostems from plants infected with 
easA RNAi and overexpression transformants, to measure accumulation of easA 
mRNA. Quantities of transcripts of dmaW also were determined, since dmaW controls 
the first determinant step of the ergot pathway (Wang et al., 2004). Similarly, mRNA of 
tefA, which encodes translation elongation factor 1-α, was measured to estimate the 
relative amount of metabolically active fungal biomass among the tissues. RT-PCR 
analysis was performed on plants representing three different easA RNAi 
Neotyphodium sp. Lp1 transformants (easA-RNAi-1, easA-RNAi-2 and easA-RNAi-3) 
and three easA overexpression Neotyphodium sp. Lp1 strains (easA-overexpression-1, 
easA-overexpression-2 and easA-overexpression-3). The data are depicted in Figures 2 
and 3 respectively. 
Data from RT-PCR analysis of easA gene in RNAi 1 and 2 transformants indicate 
that the lower levels of mRNA of easA resulted in lower accumulation of pathway end 
product ergovaline and higher accumulation of chanoclavine and shunt product 6,7-
secolysergine (Fig. 2A and B). In overexpression transformants 1 and 2, the high 
quantities of easA mRNA are consistent with the observed differences in ergot alkaloid 
accumulation in these transformants (Fig. 3A and B). The concentrations of tefA mRNA 
indicated that there was no significant difference in fungal biomass between the 
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transformants and wild type (Fig 2 and 3). Data from easA-RNAi-3 and easA-
overexpression-3 strains did not show any significant difference in the expression of the 
ergot pathway genes when compared to wild type, which supports the lack of difference 
observed in the alkaloid data (Fig. 2C and 3C). 
 
CONCLUSION 
Collectively, results from this study demonstrate that the ergot pathway inefficiency 
which results in differential accumulation of ergot alkaloids in different tissues of the 
grass plant is strictly regulated and is atleast in part under the control of tightly regulated 
expression of ergot pathway genes. RT-PCR analysis of easA gene indicates that the 
observed variation in the ergot alkaloid profile of RNAi and overexpression 
transformants coincides with the change in mRNA abundance of easA gene.  
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FIGURE LEGENDS 
Figure 1: Abundance of mRNA from indicated ergot alkaloid genes in pseudostem, 
center leaf, outer leaf, flag leaf, inflorescence and dough stage seeds (in the order 
represented by graphical form) of perennial ryegrass infected with wild-type 
Neotyphodium sp. Lp1 (n=3). Expression of all tested genes was calculated with the 
relative comparative Ct method using tefA as the reference gene for normalization. 
 
Figure 2: Abundance of mRNA from indicated genes in pseudostem of perennial 
ryegrass plant infected with Neotyphodium sp. Lp1 RNAi-1, 2 and 3 transformant strains 
(A-C respectively). Expression of all tested genes was calculated with the relative 
comparative Ct method using tefA as the reference gene for normalization. 
 
Figure 3: Abundance of mRNA from indicated genes in pseudostem of perennial 
ryegrass plant infected with Neotyphodium sp. Lp1 overexpression-1, 2 and 3 
transformant strains (A-C respectively) (n=3). Expression of all tested genes was 
calculated with the relative comparative Ct method using tefA as the reference gene for 
normalization. 
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Table1: Primers used in real-time quantitative PCR assays 
Primer name Sequence 
TQM_tefA_F2  TGC GCT ATC CTG ATT ATC GCT GCT 
TQM_tefa_R2 TTG ATG GCA ACG ATG AGC TGC TTG 
dmaW_RT(f) AGC CAG GCA TAG ACC TTC AA 
dmaW_RT(r)  GAG CCA AAC ACA AGC TCC TG 
Lolium EF1-fwd TTG AGA GGT CCA CCA ACC TTG ACT 
Lolium EF1-rev GCA CAG TTC CAA TGC CAC CAA TCT 
easA_RT2_f GTC GTC CAT GGT GCC CAT TC 
easA_RT2_r TCG AAC TCC ACG GTG CCA AT 
cloA_RT1_f AGG GAC GAT TTT CCT CAC GCT 
cloA_RT1_r GAT GTG AAC ATG GTT TGG GCC 
easC_RT2_f CAA GGG CAT GGC AGT CAA GTT 
easC_RT2_r GGC CAA CAT ACG CAC TCA TAC 
lpsA_RT2_f CCA GCA ATG CCT TGT ATG CAG T 
lpsA_RT2_r ACG TCG CCT GTA GCT CTC TCA T 
easD_RT2_f AGT GCC GTC AAC AAG TGG TT 
easD_RT2_r ACT GGC CAC GTT GAC GAT ACT 
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FIGURE 1. 
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FIGURE 2. 
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FIGURE 3. 
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SUMMARY 
 
I studied the two fungi, Aspergillus fumigatus and Neotyphodium sp. Lp1, in order to 
investigate potential mechanisms affecting accumulation and transition of alkaloids 
down the ergot alkaloid pathway. Each fungus provides advantages for addressing 
different questions related to ergot pathway inefficiency. 
 
Aspergillus fumigatus provides the advantage of having distinct cell types, 
enabling me to study potential differences in the expression of different ergot alkaloid 
pathway genes among these cell types. Previous results had demonstrated that ergot 
alkaloids accumulate in or on conidia (Panaccione and Coyle, 2005; Coyle et al., 2007); 
however, results from studies of wild type and mutant A. fumigatus demonstrated that 
ergot alkaloids are produced in other cell types that constitute a developing 
conidiophore. Furthermore, ergot alkaloid profiles from isolated mature conidia and 
preparations that contained all cell types differed significantly, indicating cell-type 
specific differences in ergot alkaloid accumulation. GFP expression studies of different 
ergot alkaloid genes showed that these cell specific differences in alkaloid accumulation 
are not due to qualitative but rather quantitative cell-type specific differences in the 
expression of individual pathway genes. 
 
Neotyphodium sp. Lp1, an endophyte of perennial rye grass accumulates 
different profile of ergot alkaloids in comparison to A. fumigatus and also serves as a 
good model system to study the pathway inefficiency at tissue specific level of the host 
plant. I found that ergot alkaloid pathway efficiency varied in different tissues. My data, 
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considered along with data provided by S. Florea and C. Schardl (University of 
Kentucky) indicate that relative mRNA abundance of different ergot alkaloid pathway 
genes was a significant factor in the different ergot alkaloid profiles observed among 
different tissues. My attempts to genetically modify pathway efficiency by knocking 
down and overexpressing easA changed the ergot alkaloid profile of Neotyphodium sp. 
Lp1. RNAi mediated knock down of easA resulted in higher accumulation of the 
pathway intermediate chanoclavine and shunt product 6,7-secolysergine and lower 
accumulation of pathway end product ergovaline. In contrast, overexpression of easA 
resulted in higher accumulation of ergovaline and no significant change in the levels of 
pathway intermediates or shunt products. Therefore, in Neotyphodium sp. Lp1, the 
abundance of easA mRNA has a significant role in controlling the efficiency in the flow 
of intermediates down the ergot alkaloid pathway.  
This research has demonstrated potential mechanisms involved in the control of 
ergot alkaloid pathway efficiency and also has developed strategies in controlling 
pathway efficiency. Manipulation of endophyte ergot alkaloid profiles may have utility in 
studies of the effects of specific alkaloids in animal toxicosis or in protecting grasses 
from insects. 
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